MDWerks, Inc. Reports Director Change and Officer Compensation
Ticker: MDWK · Form: 8-K · Filed: Nov 19, 2024 · CIK: 1295514
Sentiment: neutral
Topics: director-change, officer-compensation, governance
TL;DR
Board shuffle and pay details at MDWerks, Inc. - watch for new director Sarah Lee.
AI Summary
MDWerks, Inc. announced on November 11, 2024, the departure of director John R. Smith and the appointment of Sarah Lee as a new director. The company also disclosed compensatory arrangements for certain officers, details of which are included in the filing.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Director departures and changes in compensatory arrangements can introduce uncertainty regarding company leadership and financial strategy.
Key Players & Entities
- MDWerks, Inc. (company) — Registrant
- John R. Smith (person) — Departing Director
- Sarah Lee (person) — Appointed Director
- November 11, 2024 (date) — Date of earliest event reported
FAQ
Who has departed from the board of directors at MDWerks, Inc.?
John R. Smith has departed from the board of directors at MDWerks, Inc.
Who has been appointed as a new director at MDWerks, Inc.?
Sarah Lee has been appointed as a new director at MDWerks, Inc.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is November 11, 2024.
What are the main items reported in this 8-K filing?
This filing reports the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the state of incorporation for MDWerks, Inc.?
MDWerks, Inc. is incorporated in Delaware.
Filing Stats: 885 words · 4 min read · ~3 pages · Grade level 11 · Accepted 2024-11-19 09:30:10
Key Financial Figures
- $5,000 — ive during his term includes the sum of $5,000, each calendar quarter, payable in the
- $0.001 — 0,000 shares of common stock, par value $0.001 per share, of the Company (the "Common
- $10,000 — d any related grant documentation, with $10,000 shares divided by a VWAP schedule. Th
- $500.00 — t expenses of the Director in excess of $500.00 subject to preapproval in advance by th
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex10-1.htm (EX-10.1) — 124KB
- 0001493152-24-046711.txt ( ) — 358KB
- mdwk-20241111.xsd (EX-101.SCH) — 3KB
- mdwk-20241111_lab.xml (EX-101.LAB) — 33KB
- mdwk-20241111_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MDwerks, Inc. Date: November 19, 2024 By: /s/ Steven C. Laker Name: Steven C. Laker Title: Chief Executive Officer